Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from AdAlta Ltd. ( (AU:1AD) ) is now available.
AdAlta Ltd. announced the issuance of 2,000,000 new options, set to expire on June 3, 2028, as part of a securities quotation application. This move, managed by Mahe Capital, is part of a broader fundraising effort outlined in their May 2025 prospectus, potentially strengthening AdAlta’s financial position and market presence.
More about AdAlta Ltd.
AdAlta Ltd. operates in the biotechnology industry, focusing on the development of innovative therapeutic products. The company is known for its work in advancing biologics and other medical solutions, targeting unmet medical needs in various markets.
Average Trading Volume: 1,060,063
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.52M
Find detailed analytics on 1AD stock on TipRanks’ Stock Analysis page.